Max Robotics — Global Service Robot Directory + US Certification

About

Calogero Catanzaro is a leading surgical outcomes researcher whose work is reshaping our understanding of robotic versus open approaches in major oncologic surgery. His research focuses on comparative effectiveness, perioperative safety, and age-specific outcomes in urologic oncology—particularly for prostate and bladder cancers. Catanzaro’s most impactful study, “Costs of robot-assisted vs. open approaches for 5 major cancers” (2025, 8 citations), provides a comprehensive cost-analysis framework that has become essential for hospital decision-makers weighing technology adoption against traditional methods. He has also pioneered investigations into adverse in-hospital outcomes for specific populations, including young quadragenarians undergoing radical prostatectomy—a group previously overlooked in the literature. His work on urinary diversion techniques during robot-assisted radical cystectomy (4 citations) and outcomes in octogenarians (1 citation) demonstrates a commitment to precision medicine across age groups. By systematically comparing surgical approaches with rigorous attention to patient demographics and institutional costs, Catanzaro is helping to define evidence-based guidelines that balance clinical efficacy with economic sustainability. His growing citation record reflects the urgent relevance of his findings to surgeons, health policy makers, and patients navigating complex treatment decisions.